CareDx, Inc. officer Jeffrey Novack filed a Form 144 notice on November 10, 2026, proposing the sale of 4,096 shares of CareDx common stock acquired through the vesting of restricted stock units.

Key Highlights

  • Seller: Jeffrey Novack, an officer of CareDx, Inc.
  • Shares proposed for sale: 4,096 shares of CareDx common stock
  • Aggregate market value: $345,784.32, according to the filing
  • Source of shares: Restricted stock units that vested between November 1 and November 6, 2026, as stated in the filing's remarks
  • 10b5-1 plan adoption date: September 4, 2025, per the filing
  • Total shares outstanding: 52,542,786, as reported in the filing
  • No sales reported by Novack in the three months prior to this notice, according to the filing

Jeffrey Novack's Proposed Share Sale Under Rule 144 at CareDx

CareDx, Inc. (NASDAQ:CDNA), headquartered at 8000 Marina Boulevard, 4th Floor, Brisbane, California 94005, was identified as the issuer in the Form 144 notice. The filing was submitted on November 10, 2026, by Jeffrey Novack, who is listed as an officer of the company. The notice covers a proposed sale of 4,096 shares of CareDx common stock, with an aggregate market value of $345,784.32, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

According to the filing, the shares were acquired through restricted stock units granted by the issuer, with an acquisition date of November 1, 2026, and a payment date of November 1, 2026. The filing's remarks section states that "the securities to be sold were acquired upon the vesting of restricted stock units during the period of 11/01/2026 through 11/06/2026." The approximate date of sale listed in the notice is November 10, 2026.

The filing indicates that the proposed sale is being conducted in reliance on a Rule 10b5-1 written trading plan, with a plan adoption date of September 4, 2025. Novack reported no sales of CareDx securities in the three months preceding this notice. The total number of shares of common stock outstanding at the time of filing was listed as 52,542,786.

What Was Disclosed

Jeffrey Novack, an officer of CareDx, Inc., filed a Form 144 notice proposing to sell 4,096 shares of common stock valued at $345,784.32 in aggregate, acquired via restricted stock unit vesting, under a Rule 10b5-1 plan adopted September 4, 2025.